294 related articles for article (PubMed ID: 22789673)
1. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma.
Ahn YH; Shin PM; Oh NR; Park GW; Kim H; Yoo JS
J Proteomics; 2012 Sep; 75(17):5507-15. PubMed ID: 22789673
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of aberrant protein glycosylation in liver cancer plasma by AAL-enrichment and MRM mass spectrometry.
Ahn YH; Shin PM; Kim YS; Oh NR; Ji ES; Kim KH; Lee YJ; Kim SH; Yoo JS
Analyst; 2013 Nov; 138(21):6454-62. PubMed ID: 24027776
[TBL] [Abstract][Full Text] [Related]
3. Differential proteomic approach for identification and verification of aberrantly glycosylated proteins in adenocarcinoma lung cancer (ADLC) plasmas by lectin-capturing and targeted mass spectrometry.
Ahn YH; Ji ES; Oh NR; Kim YS; Ko JH; Yoo JS
J Proteomics; 2014 Jun; 106():221-9. PubMed ID: 24780727
[TBL] [Abstract][Full Text] [Related]
4. A lectin-coupled, multiple reaction monitoring based quantitative analysis of human plasma glycoproteins by mass spectrometry.
Ahn YH; Shin PM; Ji ES; Kim H; Yoo JS
Anal Bioanal Chem; 2012 Feb; 402(6):2101-12. PubMed ID: 22290386
[TBL] [Abstract][Full Text] [Related]
5. Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma.
Norton P; Comunale MA; Herrera H; Wang M; Houser J; Wimmerova M; Romano PR; Mehta A
Proteomics; 2016 Dec; 16(24):3126-3136. PubMed ID: 27650323
[TBL] [Abstract][Full Text] [Related]
6. A multiplex lectin-channel monitoring method for human serum glycoproteins by quantitative mass spectrometry.
Ahn YH; Ji ES; Shin PM; Kim KH; Kim YS; Ko JH; Yoo JS
Analyst; 2012 Feb; 137(3):691-703. PubMed ID: 22158852
[TBL] [Abstract][Full Text] [Related]
7. A quantitative analytical method for PIVKA-II using multiple reaction monitoring-mass spectrometry for early diagnosis of hepatocellular carcinoma.
Sohn A; Kim H; Yu SJ; Yoon JH; Kim Y
Anal Bioanal Chem; 2017 Apr; 409(11):2829-2838. PubMed ID: 28168546
[TBL] [Abstract][Full Text] [Related]
8. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
Dalal K; Dalal B; Bhatia S; Shukla A; Shankarkumar A
Clin Chim Acta; 2019 Aug; 495():309-317. PubMed ID: 31014754
[TBL] [Abstract][Full Text] [Related]
9. Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein.
Korekane H; Hasegawa T; Matsumoto A; Kinoshita N; Miyoshi E; Taniguchi N
Biochim Biophys Acta; 2012 Sep; 1820(9):1405-11. PubMed ID: 22233759
[TBL] [Abstract][Full Text] [Related]
10. Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.
Sun C; Chen P; Chen Q; Sun L; Kang X; Qin X; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):765-73. PubMed ID: 22751611
[TBL] [Abstract][Full Text] [Related]
11. Glycoproteomic discovery of serological biomarker candidates for HCV/HBV infection-associated liver fibrosis and hepatocellular carcinoma.
Kaji H; Ocho M; Togayachi A; Kuno A; Sogabe M; Ohkura T; Nozaki H; Angata T; Chiba Y; Ozaki H; Hirabayashi J; Tanaka Y; Mizokami M; Ikehara Y; Narimatsu H
J Proteome Res; 2013 Jun; 12(6):2630-40. PubMed ID: 23586699
[TBL] [Abstract][Full Text] [Related]
12. Clinical Assay for AFP-L3 by Using Multiple Reaction Monitoring-Mass Spectrometry for Diagnosing Hepatocellular Carcinoma.
Kim H; Sohn A; Yeo I; Yu SJ; Yoon JH; Kim Y
Clin Chem; 2018 Aug; 64(8):1230-1238. PubMed ID: 29875214
[TBL] [Abstract][Full Text] [Related]
13. MRM validation of targeted nonglycosylated peptides from N-glycoprotein biomarkers using direct trypsin digestion of undepleted human plasma.
Lee JY; Kim JY; Cheon MH; Park GW; Ahn YH; Moon MH; Yoo JS
J Proteomics; 2014 Feb; 98():206-17. PubMed ID: 24434586
[TBL] [Abstract][Full Text] [Related]
14. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
Sanda M; Pompach P; Brnakova Z; Wu J; Makambi K; Goldman R
Mol Cell Proteomics; 2013 May; 12(5):1294-305. PubMed ID: 23389048
[TBL] [Abstract][Full Text] [Related]
15. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.
Kim H; Kim K; Yu SJ; Jang ES; Yu J; Cho G; Yoon JH; Kim Y
PLoS One; 2013; 8(5):e63468. PubMed ID: 23717429
[TBL] [Abstract][Full Text] [Related]
16. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
[TBL] [Abstract][Full Text] [Related]
17. One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature.
Dela Rosa MA; Chen WC; Chen YJ; Obena RP; Chang CH; Capangpangan RY; Su TH; Chen CL; Chen PJ; Chen YJ
Anal Chem; 2017 Apr; 89(7):3973-3980. PubMed ID: 28323416
[TBL] [Abstract][Full Text] [Related]
18. Multifucosylated Alpha-1-acid Glycoprotein as a Novel Marker for Hepatocellular Carcinoma.
Tanabe K; Kitagawa K; Kojima N; Iijima S
J Proteome Res; 2016 Sep; 15(9):2935-44. PubMed ID: 27354006
[TBL] [Abstract][Full Text] [Related]
19. Reverse lectin ELISA for detecting fucosylated forms of α1-acid glycoprotein associated with hepatocellular carcinoma.
Åström E; Stål P; Zenlander R; Edenvik P; Alexandersson C; Haglund M; Rydén I; Påhlsson P
PLoS One; 2017; 12(3):e0173897. PubMed ID: 28296934
[TBL] [Abstract][Full Text] [Related]
20. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.
Comunale MA; Rodemich-Betesh L; Hafner J; Wang M; Norton P; Di Bisceglie AM; Block T; Mehta A
PLoS One; 2010 Aug; 5(8):e12419. PubMed ID: 20811639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
